89bio Inc (ETNB)

25.76 +0.43  +1.70% NASDAQ May 29, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events


Date Type Description
08/17/2020 Earnings 89bio Inc Second Quarter Earnings Results for 2020
06/22/2020 09:00 PDT Misc 89bio Inc Annual General Meeting for 2019
05/13/2020 Earnings 89bio Inc First Quarter Earnings Results for 2020
03/18/2020 Earnings 89bio Inc Fourth Quarter Earnings Results for 2019
03/18/2020 Misc 89bio Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: https://www.89bio.com
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Aug. 17, 2020
  • Last Earnings Release: May. 13, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: 89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.